Orbimed Advisors Llc - Mar 31, 2025 SCHEDULE 13G/A Report for C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share (CCCC)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
OrbiMed Capital LLC
Security
C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
CCCC
Shares outstanding
70.5M shares
Disclosed Ownership
4.66M shares
Ownership
6.6%
Form type
SCHEDULE 13G/A
Date filed
5/15/2025, 08:09 PM
Date of event
Mar 31, 2025
SEC
View on sec.gov

Reporting Managers (2)